Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Fabien Grimaud,1 Guillaume Penaranda,2 Chloé Stavris,3 Frédérique Retornaz,3 Véronique Brunel,4 Sylvie Cailleres,4 Hervé Pegliasco,5 Jacques Le Treut,5 Vincent Grisoni,6 Emilie Coquet,1 Laurent Chiche,3 Amélie Rognon1 1Department of Pharmacy, Hôpital Européen, Marseille, France; 2Department of Biost...

Full description

Saved in:
Bibliographic Details
Main Authors: Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
immunotherapy
elderly
pd-1 inhibitor
pdl-1 inhibitor
safety
immune-related adverse events
solid tumours
prognostic biomarkers.
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/cf0fa7d1c6224b17bb4974e05a1f4225
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items